The National Institutes of Health’s cover photo
The National Institutes of Health

The National Institutes of Health

Biotechnology Research

Bethesda, MD 1,144,574 followers

About us

NIH is the only agency of its kind. We impact the health of the country and the world through unique and innovative medical research. Did you know that NIH is the largest public funder of biomedical research in the world, investing more than $32 billion a year to enhance life, and reduce illness and disability? NIH funded research has led to breakthroughs and new treatments, helping people live longer, healthier lives, and building the research foundation that drives discovery. Whether you are graduating with a bachelor's degree, working on your doctoral degree, entering the workforce for the first time, or changing careers, NIH offers a place for you to start and plenty of room to grow your career. When you join us, you’re not just advancing your career — you’re driving the health of our country forward. Official LinkedIn Account of the NIH. Privacy policy: http://go.usa.gov/x9svN Comment policy: https://bit.ly/3G6xq94 Engagement ≠ endorsement

Website
http://www.nih.gov
Industry
Biotechnology Research
Company size
10,001+ employees
Headquarters
Bethesda, MD
Type
Government Agency
Specialties
Intramural Medical Research, Extramural Medical Research, Federal Grant Funding, Scholarship Funding, Medical Research Training, and Biomedical Training at all academic levels

Locations

Employees at The National Institutes of Health

Updates

  • “Since my first day as a fellow here, my ideas have been taken seriously.” Dr. Bari Rosenberg appreciates the openness to new ideas she has found as a clinical fellow at NIH, and how working directly with patients participating in clinical trials is a unique experience to advance medicine. Learn more about NCI Clinical Fellowship opportunities: https://bit.ly/46DUtqR

  • NEWS: A new NIH-funded study suggests education can help mitigate long-term dementia risk. The scientists found that a United Kingdom education reform, which extended the minimum drop-out age by a year, reduced dementia incidence up to 50 years later. Study participants whose genetics placed them at higher risk of developing Alzheimer's Disease (AD) and AD-Related Dementias benefited most from the reform. Read the full story ➡️ https://bit.ly/4zQandV

    • No alternative text description for this image
  • NEWS: Early results of the first clinical trial to evaluate the drug invikafusp alfa (invika) in humans indicate the new treatment could manage cancers that have rebuffed other interventions, including standard immunotherapy. A study led by NIH researchers and others found that, at optimal doses, invika was well tolerated. The drug also halted disease progression in most patients and shrank tumors in others whose solid tumors had resisted standard immunotherapy. Read the full story ➡️ https://bit.ly/4zVvufb

    • No alternative text description for this image
  • 📣Join us Oct. 28 at 1:30pm ET for the next installment of the Scientific Freedom Lecture series, titled “Science is Under Attack: How Can We Save it?” NIH Director Jay Bhattacharya will lead the event featuring an in-depth discussion with Dr. Martin Kulldorff about the scientific community’s role in rebuilding public trust in health sciences research after the COVID-19 pandemic. Dr. Kulldorff is a noted biostatistician, epidemiologist, and author who currently serves as Chief Science and Data Officer in the HHS Office of the Assistant Secretary for Planning and Evaluation. NIH staff are invited to attend Dr. Kulldorff’s lecture in the Lipsett Auditorium located in Building 10 of the main NIH campus in Bethesda, Maryland. Non-NIH personnel are invited to stream the talk online. ➡️ https://bit.ly/4yzutIn

    • No alternative text description for this image
  • 🙌Today we’re shouting out the amazing work being done by our NIH Clinical Center pharmacy staff, during National Pharmacy Week! These talented men and women are essential to ensuring our patients receive the best and safest possible treatment while spending time in our care. Their many contributions include: • Advising clinicians to make sure our patients receive safe and effective medication therapy. • Reviewing medication orders for completeness and accuracy. • Ensuring medications are appropriately prepared, dispensed, and delivered. • Participating in hospital rounds where they identify and flag issues of concern in real time. • Providing guidance on drug selection and dosing. Visit the NIH Clinical Center website to learn more about the department and the exciting work being done to help Americans live long, healthier lives. ➡️ https://bit.ly/4icNXMT

    • No alternative text description for this image
  • 👩 Calling all women’s health researchers and health professionals! NIH is proud to announce the COMpetency in Menopause & Integrated Therapy (COMMIT) Challenge! This challenge seeks to achieve two primary goals: • Goal One: To identify and reward exemplary curricula for integrating effective and scalable menopause training across health professions. • Goal Two: To identify and reward the development of specialty-specific curricula tailored to distinct professional disciplines. Learn more and register for an informational webinar on 10/26 ➡️ https://bit.ly/4zJ9kMR

    • A person sitting on a sofa looks to the right. In front of them, a graphic reads: "Competency in Menopause & Integrated Therapy (COMMIT) Challenge. Recognizing exemplary approaches to menopause education for health care professionals. Total cash prizes: $2,500,000." The National Institutes of Health (NIH) logo is at the bottom.
  • The cerebellum is a part of the brain primarily known to be involved in movement and coordination. A new study conducted by NIH Stadtman Investigator Dr. Mark Wagner and his lab shows it could also play a pivotal role in learning and retaining new skills. Their findings shed new light on the cerebellum—quite literally—and could help explain how the brain reuses what it already knows to learn new tasks without getting its wires crossed.

  • 🎉 Congratulations to four NIH researchers and leaders newly elected to the National Academy of Medicine (NAM) — one of the highest honors in health and medicine! 🏅 Dr. Anthony Letai, NCI Director 🏅 Dr. Francesco DeMayo, NIEHS Senior Investigator 🏅 Dr. Swee Lay Thein, NHLBI Senior Investigator 🏅 Dr. Daniel S. Reich, NINDS Senior Investigator This honor recognizes outstanding professional achievement and a lasting commitment to service — and it's a perfect reflection of the scientific leadership and dedication NIH researchers bring to advancing biomedical research and improving health for all. 👏 Congratulations on this incredible, well-deserved achievement! 🔗 Meet the newly elected NAM members: https://bit.ly/4eMCbrA

    • This image announces the election of four NIH researchers to the National Academy of Medicine. Each researcher is shown in a separate inset with their name, title, and affiliation. From left to right: Francesco DeMayo, Anthony Letai, Swee Lay Thein, and Daniel S. Reich. The background includes the NIH logo and decorative elements.
  • NIH researchers have discovered a previously unknown natural defense mechanism involving GIMAP6, an immune-regulating protein that may help the body prevent plaque from building up inside arteries. The discovery could open new possibilities for treating atherosclerotic cardiovascular disease (ASCVD), a leading cause of death in the U.S. Read more ⤵️

  • How does environmental pollution affect fetal development? NIH-supported researchers created a placenta-on-a-chip to find out. The model revealed new risks linked to toxic metal exposure during pregnancy and hints at how the placenta may help protect a developing fetus.

Affiliated pages

Similar pages

Browse jobs